Back to Authors

Metersky, Mark L.

https://orcid.org/0000-0003-1968-1400

A5017144404 | I75929689

Mayo Clinic

UConn Health

Citations 23

Clinical Features of Patients With an Eosinophilic Phenotype: An Analysis of the U.S Bronchiectasis and NTM Research Registry

B103. HOT TOPICS IN CYSTIC FIBROSIS, BRONCHIECTASIS, AND BREATHLESSNESS | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A4310-A4310

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4310

Cftr Mutation and Increased Rates of Pulmonary Infections Among Patients From the US Bronchiectasis and NTM Research Registry

B98. THE HAPPY COUPLE: BRONCHIECTASIS AND NONTUBERCULOUS MYCOBACTERIA | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A4244-A4244

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4244

Gastroesophageal Reflux Disease (GERD) and Pulmonary Exacerbation Frequency in Bronchiectasis Patients from the Bronchiectasis and NTM Research Registry (BRR)

C28. LET'S TALK NTM | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A3870-A3870

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3870

Nontuberculous Mycobacteria (NTM) Isolation Status Relative to Pulmonary Exacerbation Frequency in Bronchiectasis Patients: Results from the Bronchiectasis and NTM Research Registry (BRR)

C28. LET'S TALK NTM | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A3867-A3867

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3867

Racial, Ethnic, and Socioeconomic Disparities in Treatment and Outcomes of Patients with Bronchiectasis and Nontuberculous Mycobacteria (NTM)

TP32. TP032 EPIDEMIOLOGY, BIOMARKERS, AND THERAPY IN CF AND NON-CF BRONCHIECTASIS | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A2013-A2013

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2013

Comparing Clinical Characteristics and Outcomes in Patients with Non-Cystic Fibrosis Bronchiectasis with Non-Tuberculous Mycobacteria and/or Pseudomonas Aeruginosa Within the US Bronchiectasis and NTM Research Registry

D104. PHENOTYPES, PROGNOSTIC TOOLS, AND ADJUNCT THERAPIES IN COUGH, CF AND NON-CF BRONCHIECTASIS | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A7764-A7764

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7764

The Association of Chronic Macrolide Treatment and Incident Isolation of Non-Tuberculous Mycobacteria in Patients with Bronchiectasis

D12. EPIDEMIOLOGY AND THERAPY IN CF AND NON-CF BRONCHIECTASIS | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A6200-A6200

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6200

Pulmonary Nontuberculous Mycobacterial Infection in Patients in the U.S. Bronchiectasis Research Registry: Use of Antibiotic Therapy and Adverse Events

B106. BREAKTHROUGHS IN NTM DIAGNOSIS AND TREATMENT | July 7, 2020 | Volume: No volume available | Issue: No issue available | Pages: A4358-A4358

10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4358

Pseudomonas Aeruginosa Associated with Severity of Non-Cystic Fibrosis Bronchiectasis Measured by the Modified Bronchiectasis Severity Score (BSI) and the FACED: The US Bronchiectasis and NTM Research Registry (BRR) Study

C105. BRONCHIECTASIS: FROM CLINICAL PHENOTYPES TO TREATMENT | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A5716-A5716

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5716

Airway Clearance in Non-Cystic Fibrosis Bronchiectasis: Analysis from the United States Bronchiectasis Research Registry

C105. BRONCHIECTASIS: FROM CLINICAL PHENOTYPES TO TREATMENT | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A5700-A5700

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5700